Orion OYJ (ORINY) Stock Price, News & Analysis

Company Overview

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets. Its products are sold in numerous countries, with the company maintaining a particularly strong presence in the Nordic region.

Orion is led by President and Chief Executive Officer Liisa Hurme. The company is listed on Nasdaq Helsinki, while its shares also trade in the U.S. over-the-counter market under the symbol ORINY.

Key Stats

• Today's Range: $47.16 to $47.16
• 50-Day Range: $38.54 to $47.16
• 52-Week Range: $30.89 to $47.16
• Volume: 143 shs
• Average Volume: 266 shs
• Market Capitalization: $13.31 billion
• P/E Ratio: 19.41
• Dividend Yield: 0.81%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Orion OYJ Stock Analysis - MarketRank™

Orion OYJ scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Orion OYJ has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Orion OYJ has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Orion OYJ is 19.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orion OYJ is 19.41, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.13.

Price to Book Value per Share Ratio

Orion OYJ has a P/B Ratio of 9.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Orion OYJ has been sold short.

Short Interest Ratio / Days to Cover

Orion OYJ has a short interest ratio ("days to cover") of 3.61, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orion OYJ has recently increased by 256.86%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Orion OYJ has a dividend yield of 0.82%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Orion OYJ does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Orion OYJ is 15.64%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: N/A

News Sentiment

Orion OYJ has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Orion OYJ this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Orion OYJ insiders have not sold or bought any company stock.

Percentage Held by Institutions

Orion OYJ has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/17/2026
• Today: 9/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ORINY
• Previous Symbol: NASDAQ:ORINY
• CIK: N/A
• Web: www.orion.fi
• Phone: 358 10 4261
• Fax: N/A
• Employees: 4,029
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $2.43
• Trailing P/E Ratio: 19.41
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $566.04 million
• Net Margins: 28.52%
• Pretax Margin: 35.39%
• Return on Equity: 50.37%
• Return on Assets: 30.65%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 2.64
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $2.14 billion
• Price / Sales: 6.23
• Cash Flow: $2.29 per share
• Price / Cash Flow: 20.61
• Book Value: $5.15 per share
• Price / Book: 9.16

Miscellaneous

• Outstanding Shares: 282,270,000
• Free Float: N/A
• Market Cap: $13.31 billion
• Optionable: Not Optionable
• Beta: 0.08